Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide.

Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide.

Item
http://www.wikidata.org/entity/Q40640090
Atrial Fibrillation: The Science behind Its DefiancePentamidine reduces hERG expression to prolong the QT interval.Effects of 4-aminopyridine on action potentials generation in mouse sinoauricular node strips.KCNH2 pharmacogenomics summary.Role of abnormal repolarization in the mechanism of cardiac arrhythmia.Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine.Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells.Procainamide and lidocaine produce dissimilar changes in ventricular repolarization and arrhythmogenicity in guinea-pig.Arrhythmogenic drugs can amplify spatial heterogeneities in the electrical restitution in perfused guinea-pig heart: An evidence from assessments of monophasic action potential durations and JT intervals.
P2860

Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide.

Item
http://www.wikidata.org/entity/Q40640090
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Characterisation of recombinan ...... iarrhythmic drug procainamide.
@en
type
label
Characterisation of recombinan ...... iarrhythmic drug procainamide.
@en
prefLabel
Characterisation of recombinan ...... iarrhythmic drug procainamide.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Characterisation of recombinan ...... tiarrhythmic drug procainamide
@en
P2093
P304
P31
P356
10.1016/S0006-291X(03)00980-X
P433
P478
P50
P577
P698